Ocugen (OCGN) Capital Expenditures (2014 - 2026)

Ocugen (OCGN) has 13 years of Capital Expenditures data on file, last reported at $6000.0 in Q1 2026.

• Quarterly Capital Expenditures fell 62.5% year-over-year to $6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $175000.0 (down 83.32% YoY) and the FY2025 annual result came in at $185000.0, down 94.53% from the prior year.
• Capital Expenditures eased to $6000.0 in Q1 2026, from $166000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $5.1 million in Q3 2023 to a low of -$5.6 million in Q4 2023.
• A 5-year average of $392705.9 and a median of $43000.0 in 2025 frame the typical range for Capital Expenditures.
• The widest YoY moves for Capital Expenditures: up 1529.33% in 2023, down 1639.06% in 2023.
• Tracing OCGN's Capital Expenditures over 5 years: stood at -$320000.0 in 2022, then sank by 1639.06% to -$5.6 million in 2023, then jumped by 100.23% to $13000.0 in 2024, then surged by 1176.92% to $166000.0 in 2025, then tumbled by 96.39% to $6000.0 in 2026.
• The last three Capital Expenditures figures came in at $6000.0 (Q1 2026), $166000.0 (Q4 2025), and -$40000.0 (Q3 2025), per Business Quant data.